Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT02114931

Public ClinicalTrials.gov record NCT02114931. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this open-label study is to evaluate the long-term safety and efficacy of ABP 501 in adults with moderate to severe rheumatoid arthritis (RA).

Study identification

NCT ID
NCT02114931
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
467 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 81 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2014 (Type not available)
Primary completion
Apr 2016 (Actual)
Completion
Apr 2016 (Actual)
Last update posted
Apr 24, 2017

2014 – 2016

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Research Site Huntsville Alabama 35801 —
Research Site Peoria Arizona 85381 —
Research Site Scottsdale Arizona 85258 —
Research Site Covina California 91723 —
Research Site El Cajon California 92020 —
Research Site Hemet California 92543 —
Research Site Palm Desert California 92260 —
Research Site Van Nuys California 91405 —
Research Site Whittier California 90602 —
Research Site Danbury Connecticut 06810 —
Research Site Miami Florida 33015 —
Research Site Orlando Florida 32804 —
Research Site Sarasota Florida 34233 —
Research Site Sandy Springs Georgia 30328 —
Research Site Lexington Kentucky 40504 —
Research Site Hagerstown Maryland 21740 —
Research Site Wheaton Maryland 20902 —
Research Site St Louis Missouri 63141 —
Research Site Omaha Nebraska 68114 —
Research Site Brooklyn New York 11201 —
Research Site Mineola New York 11501 —
Research Site Oklahoma City Oklahoma 73103 —
Research Site Bethlehem Pennsylvania 18015 —
Research Site Duncansville Pennsylvania 16635 —
Research Site Charleston South Carolina 29406 —
Research Site Memphis Tennessee 38119 —
Research Site Carrollton Texas 75007 —
Research Site Dallas Texas 75231 —
Research Site Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02114931, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2017 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02114931 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →